Dori, A., Guglieri, M., Scutifero, M., Passamano, L., Trabacca, L. and Politano, L. 2022. Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up. Acta Myologica. 41, 1 (Mar. 2022).